Daphne Karydas, Director: Mineralys Therapeutics MLYS Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $75,000
Shares · price: 3,000 sh · $25.00 a share
Held after: 6,200 sh
Stock: Mineralys Therapeutics MLYS
Person: Daphne KarydasDirector
Trade date: 26/06/17
Filed: 26/06/17
Days to filing: 0 days

Sold 32.6% of holdings

Share of holding sold: 32.6%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Daphne Karydas's recent trades

Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$85.7K
3,000 sh
$85.7K
Filed 09/15
Traded 09/15
Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 06/17
Traded 06/17
Daphne KarydasDirector
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 04/02
Traded 03/31
Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 03/31
Traded 03/31
Daphne KarydasDirector
SellMineralys Therapeutics
Sell
Mineralys Therapeutics
MLYS
$463.4K
10,115 sh
$463.4K
Filed 25/11/13
Traded 25/11/13